FdaApplication
ANDA 204570
Identifiers
- fda_app_no: ANDA204570
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES UT INC |
| application_type | ANDA |
| approval_date | 2019-04-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TESTOSTERONE | TESTOSTERONE | 1.62% (20.25MG/1.25GM PACKET) | GEL;TRANSDERMAL |
| TESTOSTERONE | TESTOSTERONE | 1.62% (40.5MG/2.5GM PACKET) | GEL;TRANSDERMAL |
| TESTOSTERONE | TESTOSTERONE | 1.62% (20.25MG/1.25GM ACTUATION) | GEL, METERED;TRANSDERMAL |
3 products